Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 3, 2005, Pages 702-713

  Zaider, Marco ^a   Zelefsky, Michael J ^a   Cohen, Gilad N ^a   Chui, Chen Shou ^a   Yorke, Ellen D ^a   Ben Porat, Leah ^a   Happersett, Laura ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Biological planning; Brachytherapy; Intensity modulated radiotherapy; Prostatic carcinoma; Radiotherapy

Indexed keywords

CLINICAL LABORATORIES; DOSIMETRY; FRACTIONATION; IMPLANTS (SURGICAL); PATIENT TREATMENT; RADIOTHERAPY; TISSUE; TUMORS;

CANCER CELLS; EXTERNAL BEAM RADIOTHERAPY (EBRT); MONOTHERAPY; PROSTATE CANCER;

ONCOLOGY;

AB INITIO CALCULATION; ARTICLE; BRACHYTHERAPY; CANCER CELL; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CELL LOSS; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOW ENERGY RADIATION; MALE; METHODOLOGY; PATIENT CODING; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RECTUM DISEASE; TREATMENT PLANNING; URETHRA DISEASE;

ALGORITHMS; BRACHYTHERAPY; DOSE FRACTIONATION; FEASIBILITY STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; RADIOTHERAPY, CONFORMAL;

EID: 13844254882     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.06.251     Document Type: Article

References (51)

1. A. Pollack, A. Hanlon, E.M. Horwitz, S. Feigenberg, R.G. Uzzo, R.A. Price Radiation therapy dose escalation for prostate cancer: A rationale for IMRT World J Urol 21 2003 200 208
2. H.M. Sandler Dose escalation for prostate cancer: Which dose for which person? Controversies in Uro-Oncology 36 2002 10 15
3. G.E. Hanks, A.L. Hanlon, B. Epstein, E.M. Horwitz Dose response in prostate cancer with 8-12 years' follow-up Int J Radiat Oncol Biol Phys 54 2002 427 435
4. G.E. Hanks Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma Cancer 85 1999 1204 1205
5. G.E. Hanks, A.L. Hanlon, T.E. Schultheiss Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions Int J Radiat Oncol Biol Phys 41 1998 501 510
6. G.E. Hanks, W.R. Lee, A.L. Hanlon Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen <10 ng/ml Int J Radiat Oncol Biol Phys 35 1996 861 868
7. G.E. Hanks Question-filled future for dose-escalation in prostate-cancer Int J Radiat Oncol Biol Phys 32 1995 891 893
8. M.J. Zelefsky, Z. Fuks, M. Hunt High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 166 2001 876 881
9. M.J. Zelefsky, Z. Fuks, L. Happersett Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer Radiother Oncol 55 2000 241 249
10. S.A. Leibel, Z. Fuks, M.J. Zelefsky Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer Semin Oncol 30 2003 596 615
11. H. Elsaleh, D. Joseph, S. Bydder Radiation dose escalation for prostate cancer J Clin Oncol 18 2000 4003
12. F.A. Critz, W.H. Williams, A.K. Levinson, J.B. Benton, C.T. Holladay, F.J. Schnell Simultaneous irradiation for prostate cancer: Intermediate results with modern techniques J Urol 164 2000 738 741
13. J.C. Blasko, P.D. Grimm, J.E. Sylsvester, W. Cavanagh The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma Radiother Oncol 57 2000 273 278
14. L. Potters Permanent prostate brachytherapy: Lessons learned, lessons to learn Oncology New York 14 2000 981 991
15. L. Potters, C. Cha, G. Oshinsky, E. Venkatraman, M. Zelefsky, S. Leibel Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy Cancer J Sci Amer 5 1999 301 306
16. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 1989 679 694
17. S.P. Lee, M.Y. Leu, J.B. Smathers, W.H. McBride, R.G. Parker, H.R. Withers Biologically effective dose distribution based on the linear-quadratic model and its clinical relevance Int J Radiat Oncol Biol Phys 33 1995 375 389
18. C.R. King, T.A. DiPetrillo, D.E. Wazer Optimal radiotherapy for prostate cancer: Predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models Int J Radiat Oncol Biol Phys 46 2000 165 172
19. A. Brahme, J. Nilsson, D. Belkic Biologically optimized radiation therapy Acta Oncolog 40 2001 725 734
20. A. Brahme Individualizing cancer treatment: Biological optimization models in treatment planning and delivery Int J Radiat Oncol Biol Phys 49 2001 327 337
21. J.Z. Wang, X.A. Li Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose Med Phys 30 2003 34 40
22. A.B. Jani, C.M. Hand, A.E. Lujan Biological effective dose for comparison and combination of external beam and low dose rate interstitial brachytherapy prostate cancer treatment plans Med Dosim 29 2004 42 48
23. R.K. Bode, P.M. Evans, G.D. Flux Application of the linear-quadratic model to combined modality radiotherapy Int J Radiat Oncol Biol Phys 59 2004 228 241
24. M. Zaider, H.H. Rossi The synergistic effects of different radiations Radiat Res 83 1980 732 739
25. M. Zaider, G.N. Minerbo Tumour control probability: A formulation applicable to any temporal protocol of dose delivery Phys Med Biol 45 2000 279 293
26. C.S. Wuu, M. Zaider A mathematical description of sublethal damage repair and interaction during continuous low dose-rate irradiation Radiat Protect Dosimetry 52 1994 211 215
27. R.G. Dale The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy Br J Radiol 58 1985 515 528
28. Zaider M, Dicello J. RBEOER: A Fortran program for the computation of RBEs, OERs, survival ratios and the effects of fractionation using the theory of dual radiation action. Los Alamos Scientific Laboratory Report LA-7196-MS, 1-19. 1978.
29. R.I. MacKay, J.H. Hendry, C.J. Moore, P.C. Williams, G. Read Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms Br J Radiol 70 1997 517 526
30. Thames HD, Hendry JH. Fractionation in radiotherapy. London: Taylor and Francis; 1987.
31. G.G. Steel Cellular-sensitivity to low dose-rate irradiation focuses the problem of tumor radioresistance Radiother Oncol 20 1991 71 83
32. M. Zaider, M.J. Zelefsky, L.G. Hanin, A.D. Tsodikov, A.Y. Yakovlev, S.A. Leibel A survival model for fractionated radiotherapy with an application to prostate cancer Phys Med Biol 46 2001 2745 2758
33. K.M.G. Haustermans, I. Hofland, H. VanPoppel Cell kinetic measurements in prostate cancer Int J Radiat Oncol Biol Phys 37 1997 1067 1070
34. J.C. Blasko, P.D. Grimm, J.E. Sylvester, K.R. Badiozamani, D. Hoak, W. Cavanagh Palladium-103 brachytherapy for prostate carcinoma Int J Radiat Oncol Biol Phys 46 2000 839 850
35. P.D. Grimm, J.C. Blasko, J.E. Sylvester, R.M. Meier, W. Cavanagh 10-year biochemical (prostate-specific antigen) control of prostate cancer with I-125 brachytherapy Int J Radiat Oncol Biol Phys 51 2001 31 40
36. D.J. Brenner, A.A. Martinez, G.K. Edmundson, C. Mitchell, H.D. Thames, E.P. Armour Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13
37. F. Paris, Z. Fuks, A. Kang Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice Science 293 2001 293 297
38. H.D. Suit, H.R. Withers Endothelial cells and radiation gastrointestinal syndrome [Letter] Science 294 2001 1411A
39. J.H. Hendry, C. Booth, C.S. Potten Endothelial cells and radiation gastrointestinal syndrome [Letter] Science 294 2001 1411A
40. B. Hobson, J. Denekamp Endothelial proliferation in tumors and normal-tissues--continuous labeling studies Br J Cancer 49 1984 405 413
41. M.J. Marchese, T.K. Hei, M. Zaider, G. Bayne, S. Kushner Radiation repair in human endothelial cells Int J Radiat Oncol Biol Phys 13 1987 1857 1860
42. S.A. Leibel, Z. Fuks, M.J. Zelefsky Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer Semin Oncol 30 2003 596 615
43. M.J. Zelefsky, T. Hollister, A. Raben, S. Matthews, K.E. Wallner Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer Int J Radiat Oncol Biol Phys 47 2000 1261 1266
44. D.J. Brenner Hypofractionation for prostate cancer radiotherapy--what are the issues? Int J Radiat Oncol Biol Phys 57 2003 912 914
45. D.J. Dale The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy Br J Radiol 58 1985 515 528
46. D.J. Dale Radiobiological assessment of permanent implants using tumor repopulation factors in the linear-quadratic model Br J Radiol 62 1989 241 244
47. S.L. Tucker, H.D. Thames, J.M.G. Taylor How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Radiat Res 124 1990 273 282
48. A.Y. Yakovlev Comments on the distribution of clonogens in irradiated tumors Radiat Res 134 1993 117 120
49. D.J. Brenner, E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1999 1095 1101
50. D.E. Lea, D.G. Catcheside The mechanism of the induction by radiation of chromosome aberrations in tradescantia J Genetic 44 1942 216 245
51. A.M. Kellerer, H.H. Rossi Generalized formulation of dual radiation action Radiat Res 75 1978 471 488